| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 18, 2025 | Sale | $453.27 | 1,396 | 632,759 | 30,823 | Aug 19, 2025, 05:28 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 27, 2025 | Option/RSU Exercise | - | 1,667 | - | 14,858 | Mar 03, 2025, 04:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 28, 2025 | Sale | $241.68 | 513 | 123,983 | 14,830 | Mar 03, 2025, 04:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Nov 26, 2024 | Sale | $250.98 | 1,469 | 368,686 | 14,634 | Nov 27, 2024, 05:21 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Jun 25, 2024 | Sale | $231.00 | 1,605 | 370,747 | 13,206 | Jun 26, 2024, 04:26 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 27, 2024 | Option/RSU Exercise | - | 1,667 | - | 5,737 | Feb 29, 2024, 04:18 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 28, 2024 | Sale | $155.30 | 501 | 77,805 | 5,521 | Feb 29, 2024, 04:18 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 16, 2024 | Sale | $148.06 | 1,009 | 149,397 | 4,710 | Feb 20, 2024, 04:08 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Apr 27, 2023 | Sale | $194.59 | 1,476 | 287,215 | 3,155 | Apr 28, 2023, 05:55 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 03, 2023 | Sale | $232.14 | 3,424 | 794,854 | 3,296 | Feb 03, 2023, 05:45 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 01, 2023 | Option/RSU Exercise | - | 5,025 | - | 5,025 | Feb 03, 2023, 05:45 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 02, 2023 | Sale | $226.01 | 1,601 | 361,839 | 4,952 | Feb 03, 2023, 05:45 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 03, 2022 | Sale | $210.00 | 1,754 | 368,340 | 3,629 | Aug 05, 2022, 04:15 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 04, 2022 | Tax Payment (Shares) | $191.73 | 1,788 | 342,817 | 2,011 | Aug 05, 2022, 04:15 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 05, 2022 | Sale | $218.16 | 1,841 | 401,630 | 1,692 | Aug 05, 2022, 04:15 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Jul 05, 2022 | Sale | $150.00 | 1,754 | 263,100 | 1,754 | Jul 07, 2022, 04:06 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 01, 2022 | Option/RSU Exercise | - | 5,026 | - | 5,026 | Feb 03, 2022, 04:10 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 02, 2022 | Tax Payment (Shares) | $144.67 | 1,518 | 219,609 | 3,508 | Feb 03, 2022, 04:10 PM |
